Pharmacists in San Juan, Puerto Rico
605 Pharmacists found in San Juan
Ms. Aneliese Ayala, RPH
Pharmacist
Centra Comercial Litheda 107, Carr 845 Cupey Bajo, San Juan, PR 00926
787-761-4205 787-761-1025
Mr. Angel F Rodriguez Saez
Pharmacist
Ave Borinquen #2039, San Juan, PR 00915
787-726-7558 787-728-5186
Angel Vega Rosado
Pharmacist
Urbanizacion El Vedado, 123 Calle Rodrigo De Triana, San Juan, PR 00918
787-756-6959
Dr. Angela M Febles, PHARMD
Pharmacist
Farmacias Caridad, 310 Lomas Verdes, San Juan, PR 00921
787-740-7000 787-789-3232
Ms. Angelisse Julianna Rivera Gonzalez, PHARMD
Pharmacist
Ave. Munoz Rivera #425-ng, San Juan, PR 00961
787-918-1038
Mrs. Annette Robles-ayala, R.PH.
Pharmacist
Barrio Monacillos, Centro Medico De Puerto Rico, Hospital San Juan, San Juan, PR 00926
787-766-2223 787-250-8449
Mrs. Aracely Acosta, R.PH.
1484 Ave. F.d. Roosevelt, Suite 19, San Juan, PR 00920
787-783-4510 787-792-0831
Arelys Rosado
Pharmacist
Mcs Plaza Suite 105, 255 Ave Ponce De Leon, San Juan, PR 00916
787-758-2500 787-622-2429
Arelys Almedina Colon
Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
10 Calle Casia, San Juan, PR 00921
787-641-7582
Dr. Arlene Nieves, PHARMD
Pharmacist
200 Ave Jesus T Pinero Apt 21o, San Juan, PR 00918
787-925-6181
Arnaldo Lopez
Pharmacist
Calle Loiza 2428 Punta Las Marias, San Juan, PR 00913
787-620-9612 787-727-8768
Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.